Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-09-02-2020
Volume44
Issue 9
Pages: 12

Oral Solid Dosage Equipment

GEA has expanded, integrated, and consolidated its ConsiGma continuous oral solid dosage equipment, allowing fully configurable systems that can be connected to new or existing facilities, including third-party equipment.

GEA has expanded, integrated, and consolidated its ConsiGma continuous oral solid dosage equipment, allowing fully configurable systems that can be connected to new or existing facilities, including third-party equipment.

The newly defined ConsiGma 4.0 modules can be used to transform an individual unit operation (e.g., granulation) from batch to a stand-alone, continuous operation. The system uses advanced process control software and the company’s newly developed Conductor 4.0 control system, which is compatible with supervisory control and data acquisition systems and connects to the Industrial Internet of Things.

Although the system is configurable, standard, core elements are available “off-the-shelf.” Standardization or mass customization makes continuous manufacturing equipment more affordable for a wider range of users and expedites delivery.

GEA




Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology